Atai Beckley N.V.

ATAI

Held by 1 specialist biotech fund

Share on X

Fund Holdings

RTW Investments

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

RTW InvestmentsNEWFeb 17, 2026

Shares: 2,000,000Value: $8.2M

# Signal Note: RTW Investments Enters ATAI Wong's $8.2M initiation into ATAI suggests conviction in the company's clinical pipeline, likely driven by upcoming catalysts in psychedelic-assisted therapies (psilocybin for depression/PTSD, MDMA programs). The position size (~2M shares) indicates meaningful but measured exposure, typical of Wong's staged deployment pattern ahead of Phase 2/3 readouts expected through 2024-2025.

More ATAI Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

NBIX1 fund FDMT1 fund ALURW1 fund GHRS1 fund IMCR1 fund IVEVF1 fund LRMR1 fund QURE

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: